NCT02986802View on ClinicalTrials.gov

Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes

CompletedOBSERVATIONAL
Enrollment

89,132

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

October 15, 2019

Study Completion Date

February 28, 2021

Conditions
HSV-2 InfectionPreTerm BirthPregnancy Complications
Trial Locations (1)

94612

Division of Research, Oakland

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Kaiser Permanente

OTHER

NCT02986802 - Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes | Biotech Hunter | Biotech Hunter